Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression

NCT00272025 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT00272025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression
Lead sponsor
Queen's University
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2006
Completion date
January 31, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression